Correlation Between Akari Therapeutics and Precipio
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Precipio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Precipio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Precipio, you can compare the effects of market volatilities on Akari Therapeutics and Precipio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Precipio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Precipio.
Diversification Opportunities for Akari Therapeutics and Precipio
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Akari and Precipio is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Precipio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Precipio and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Precipio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Precipio has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Precipio go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Precipio
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Precipio. In addition to that, Akari Therapeutics is 4.94 times more volatile than Precipio. It trades about -0.29 of its total potential returns per unit of risk. Precipio is currently generating about -0.17 per unit of volatility. If you would invest 626.00 in Precipio on August 30, 2024 and sell it today you would lose (54.00) from holding Precipio or give up 8.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Precipio
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Precipio |
Akari Therapeutics and Precipio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Precipio
The main advantage of trading using opposite Akari Therapeutics and Precipio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Precipio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precipio will offset losses from the drop in Precipio's long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| Precipio vs. Biodesix | Precipio vs. Sera Prognostics | Precipio vs. Applied DNA Sciences | Precipio vs. Caredx Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |